KCT0008948已完成未知
A 4-week pilot trial to evaluate the efficacy and safety of an multi-herbal extract MYP/MYPlus on chronic fatigue-related symptoms after COVID-19 infection or vaccination
Daejeon Korean Medicine Hospital of Daejeon University0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 13(Year) 至 70(Year)（—）
- 性别
- All
入选标准
- •? Men and women aged between 13 and 70 who have generally been healthy and have no specific diseases that cause fatigue.
- •? Individuals who have been diagnosed as recovered from COVID-19 or those who have passed 4 weeks since their second vaccination dose, and are currently experiencing severe fatigue or brain fog symptoms to the extent that it disrupts their daily life.
- •? Individuals with an mKCFQ11 score of 60 or above, or those with brain fog symptoms measured by VAS scoring 5 or higher.
- •? Individuals who, after receiving a detailed explanation about this clinical trial and fully understanding it, voluntarily decide to participate (in the case of minors, with the consent of their guardians) and provide written consent to comply with precautions.
排除标准
- •? Individuals who are on continuous medication for conditions/symptoms other than fatigue (excluding hypertension, hyperlipidemia, and diabetes).
- •? Those with uncontrolled hypertension (SBP of 170mmHg or higher) or prescribed insulin injections, severe anemia (Hg 9.0 g/dL or less), renal function abnormality (creatinine at 1.2 times the upper limit of the normal range), liver dysfunction or biliary tract issues (AST or ALT or Total bilirubin at 2 times the upper limit of the normal range), and thyroid dysfunction (TSH less than 0.27uIU/ml or exceeding 4.2 uIU/ml).
- •? Individuals diagnosed with or undergoing treatment for cancer, autoimmune diseases, or other known severe illnesses.
- •? Those taking medicines or health functional foods for the treatment of fatigue and brain fog.
- •? Individuals deemed by the investigator to have significant physical or mental defects that prevent them from understanding and following the overall treatment of this clinical trial.
- •? Those who have participated in another clinical trial within a month prior to the screening test.
研究者
相似试验
尚未招募
2 期
Clinical Study to evaluate the effectiveness of Linga chendooram in the management of Uthiravatha suronitham (Rheumatoid arthritis)CTRI/2023/09/057492I
尚未招募
Unknown
Clinical trial to evaluate efficacy of chitramutti madakku thailam peechu therapy in the management of thandagavathsmCTRI/2023/10/058490nil
已完成
2 期
A pilot trial to examine the effectiveness and feasibility of the mobile application-based cognitive behavioral therapy for depression and anxietydepression and anxietyJPRN-UMIN000042193Chiba University11
已完成
不适用
A pilot clinical trial to evaluate the efficacy and safety of R:GEN(Selective retina therapy) which induce to reduce drusen in patients with intermediate dry Age-related Macular DegeneratioDiseases of the eye and adnexaKCT0003227The Catholic University of Korea, Yeouido St. Mary's Hospital20
已完成
1 期
A pilot clinical trial assessing the efficacy and safety of supplementation with a B complex vitamin to reduce the incidence of chemotherapy induced peripheral neuropathy in patients diagnosed with a malignancy.Chemotherapy induced peripheral neuropathyCancer - Other cancer typesACTRN12611000078954niversity of Queensland - Centre for Integrative Clinical and Molecular Medicine135